RxDoctor Payments Data

Hao Xie, MD

Medical Oncology · Rochester, MNNPI 1417368085

Payments from drug & device makers

What this record shows

This record is dominated by education: $68 of the $68 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, AstraZeneca. That places this record below the midpoint for medical oncology clinicians in MN, where the typical reported total is $1,006.

$68in general payments, 2019–2025

Across 1 payment — averaging $68.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$68
$463,859in research payments, 2019–2025

Across 21 payments — averaging $22,089 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$268K
  • Astrazeneca UK Limited$135K
  • Biontech SE$61K

What the payments were for

  • Education$68100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca1$68

How this compares

$68 in reported general payments places this provider in the 15th percentile of 133 medical oncology providers in Minnesota.

See all medical oncology providers in Minnesota

Medicare billing

Part B allowed, 2024
$1,365,153
Medicare patients
322
Services billed
48,557

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban21$15,755
Prochlorperazine Maleate25$230
Dexamethasone36$228
Ondansetron Hcl24$170
Olanzapine19$159

Paid to pharmacies, not to this prescriber.

Other medical oncology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →